Intra vitreous injection of anti virus drug for cytomegalovirus retinitis.

Intra vitreous injection of anti virus drug for cytomegalovirus retinitis. - Intra vitreous injection of cytomegalovirus retinitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032678

Enrollment

100

Registered

2018-06-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ctomegalovirus retinitis

Interventions

Intra vitreous injection of anti CMV drugs

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases with ocular inflammation in which CMV is confirmed using intraocular fluid by polymerase chain reaction test .

Exclusion criteria

Exclusion criteria: Cases in which pathogens other than CMV were confirmed by polymerase chain reaction test Cases in which continuous administration of anti CMV drugs is difficult Cases in which systemic administration of anti-CMV drugs is possible

Design outcomes

Primary

Measure	Time frame
The activity of CMV retinitis Visual acuity	—

Countries

Japan

Contacts

Public ContactKinya Tsubota

Tokyo Medical University Ophthalmology

tsubnkin@hotmail.co.jp03-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026